FAQ: What are the risks of COVID-19 if I have inflammatory bowel disease (IBD) and are currently requiring treatment that is immunosuppressive? There is no evidence that there is an increased risk of becoming infected with the virus because of your treatment. This includes azathioprine, methotrexate and infliximab / adalimumab. There may be risk of a worse outcome if your general health is poor - usually because of active disease. The biggest risk may be prolonged steroid treatment.The current advice is to continue all current treatments but isolation precautions should be carried out to a high level. The situation is being actively monitored and advice could change as more information becomes available.